Current therapeutic strategies of OA are largely concentrated in symptomatic management, such as oral non-steroidal anti-inflammatory drugs (NSAIDs) and intra-articular steroid injections, which only provide temporary relief 3,4
The mechanical stress denatures the peptide
Reported side effects are rare and usually mild, including: Temporary fatigue Mild headaches Dizziness Injection site reactions (redness or swelling) However, due to limited long-term studies, its essential to consult with a healthcare professional before starting Epithalon therapy, especially for individuals with existing medical conditions or those taking other medications
TAS was significantly higher in SHR from the age of 3 weeks when compared with age-matched WKY rats (Table 3)
Interestingly, several of the new product listings on Amazon for BPC 157 appear to come from Alibaba sellers that offer bulk peptides available in pre-made packaging for anyone to put their brand on
Khavinson V, Diomede F, Mironova E, Linkova N, Trofimova S, Trubiani O, et al